Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPoolbeg Pharma Regulatory News (POLB)

Share Price Information for Poolbeg Pharma (POLB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.70
Bid: 13.50
Ask: 13.90
Change: 0.60 (4.58%)
Spread: 0.40 (2.963%)
Open: 13.10
High: 13.70
Low: 13.60
Prev. Close: 13.10
POLB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second Price Monitoring Extn

17 Nov 2022 14:05

RNS Number : 8121G
Poolbeg Pharma PLC
17 November 2022
 

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APMBSBDBUGBDGDR

Date   Source Headline
18th Nov 20222:00 pmRNSPrice Monitoring Extension
17th Nov 20222:05 pmRNSSecond Price Monitoring Extn
17th Nov 20222:00 pmRNSPrice Monitoring Extension
17th Nov 20227:00 amRNSCapital Markets Day
15th Nov 202210:36 amRNSPoolbeg-led consortium awarded EUR 2.3m grant
9th Nov 20221:53 pmEQSPoolbeg Pharma makes virus 'breakthrough' using AI drug discovery technology
8th Nov 20227:00 amRNSAI programme yields novel RSV drug targets
21st Oct 20227:00 amRNSUpcoming events participation
6th Oct 20224:40 pmRNSSecond Price Monitoring Extn
6th Oct 20224:35 pmRNSPrice Monitoring Extension
6th Oct 20227:00 amRNSCEO Share Purchase
4th Oct 20227:00 amRNSPOLB 001 US Patent update
21st Sep 20227:00 amRNSPoolbeg licence of Melioidosis vaccine candidate
12th Sep 20227:00 amRNSHC Wainwright Global Investment Conference
6th Sep 20222:05 pmRNSSecond Price Monitoring Extn
6th Sep 20222:00 pmRNSPrice Monitoring Extension
6th Sep 20227:00 amRNSInterim Results
31st Aug 20227:25 amRNSNotice of Results
29th Jul 20227:00 amRNSAppointment of Joint Broker
20th Jul 20227:00 amRNSPOLB001 human challenge clinical trial to commence
12th Jul 20222:06 pmRNSSecond Price Monitoring Extn
12th Jul 20222:00 pmRNSPrice Monitoring Extension
27th Jun 20227:00 amRNSProject update for AI model of RSV data
21st Jun 20224:40 pmRNSSecond Price Monitoring Extn
21st Jun 20224:36 pmRNSPrice Monitoring Extension
26th May 20222:05 pmRNSSecond Price Monitoring Extn
26th May 20222:00 pmRNSPrice Monitoring Extension
26th May 20227:00 amRNSUS patents granted for POLB 001 and POLB 002
25th May 20224:40 pmRNSSecond Price Monitoring Extn
25th May 20224:35 pmRNSPrice Monitoring Extension
23rd May 20221:01 pmRNSTR-1: Notification of major interest in shares
12th May 20227:00 amRNSGMP manufacturing contract signed
11th May 20227:00 amRNSAttendance at European Melioidosis Congress
27th Apr 20227:00 amRNSDistribution in Specie update
14th Apr 20227:00 amRNSKey POLB 002 European Patent Granted
11th Apr 20227:00 amRNSDistribution in Specie Shareholders
4th Apr 202212:26 pmRNSResult of AGM
31st Mar 20227:00 amRNSPOLB001 Update - Clinical Trial Agreement Signed
30th Mar 20227:00 amRNSCommencement of trading on US OTCQB market
24th Mar 20227:00 amRNSAI deal signed with CytoReason
9th Mar 20227:00 amRNSNotice of AGM
3rd Mar 20227:00 amRNSFinal Results
28th Feb 20227:00 amRNSNotice of Results
24th Feb 20227:00 amRNSArtificial Intelligence deal with OneThree Biotech
31st Jan 20227:00 amRNSConfirmation of vaccine platform licence execution
17th Jan 20227:00 amRNSExclusive license of RNA-based immunotherapy asset
16th Dec 20217:00 amRNSPoolbeg to develop oral vaccine delivery platform
6th Dec 20217:00 amRNSPoolbeg signs option for new vaccine candidate
25th Nov 20217:00 amRNSScientific Advisory Board Appointment
18th Nov 20217:00 amRNSUpdate on POLB 001 Clinical Development

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.